MCID: NSL004
MIFTS: 20

Nasal Cavity Lymphoma

Categories: Blood diseases, Cancer diseases, Immune diseases, Respiratory diseases

Aliases & Classifications for Nasal Cavity Lymphoma

MalaCards integrated aliases for Nasal Cavity Lymphoma:

Name: Nasal Cavity Lymphoma 12 15 73
Lymphoma of the Nasal Cavity 12
Lymphoma of Nasal Cavity 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10813
NCIt 50 C6074
UMLS 73 C1334921

Summaries for Nasal Cavity Lymphoma

MalaCards based summary : Nasal Cavity Lymphoma, also known as lymphoma of the nasal cavity, is related to b-cell lymphomas and diffuse large b-cell lymphoma. An important gene associated with Nasal Cavity Lymphoma is ANKRD11 (Ankyrin Repeat Domain 11). The drug Pembrolizumab has been mentioned in the context of this disorder. Affiliated tissues include t cells, b cells and kidney, and related phenotypes are Decreased shRNA abundance and Decreased shRNA abundance

Related Diseases for Nasal Cavity Lymphoma

Diseases related to Nasal Cavity Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 b-cell lymphomas 10.1
2 diffuse large b-cell lymphoma 9.9
3 rhinitis 9.9
4 dacryoadenitis 9.9
5 lymphoma 9.9

Graphical network of the top 20 diseases related to Nasal Cavity Lymphoma:



Diseases related to Nasal Cavity Lymphoma

Symptoms & Phenotypes for Nasal Cavity Lymphoma

GenomeRNAi Phenotypes related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance GR00251-A-1 9.23 ANKRD11 B2M
2 Decreased shRNA abundance GR00251-A-2 9.23 ANKRD11 B2M

Drugs & Therapeutics for Nasal Cavity Lymphoma

Drugs for Nasal Cavity Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):


# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Pembrolizumab Approved Phase 2 1374853-91-4

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type Recruiting NCT03728972 Phase 2 Pembrolizumab

Search NIH Clinical Center for Nasal Cavity Lymphoma

Genetic Tests for Nasal Cavity Lymphoma

Anatomical Context for Nasal Cavity Lymphoma

MalaCards organs/tissues related to Nasal Cavity Lymphoma:

41
T Cells, B Cells, Kidney, Nk Cells

Publications for Nasal Cavity Lymphoma

Articles related to Nasal Cavity Lymphoma:

(show all 15)
# Title Authors Year
1
Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder. ( 29843925 )
2018
2
Lymphoma of the nasal cavity and paranasal sinuses: A case series. ( 27657899 )
2016
3
NK/T-cell lymphoma of the nasal cavity causing contralateral dacryoadenitis. ( 23663138 )
2013
4
Diffuse large B-cell lymphoma of the nasal cavity presenting as abducens nerve palsy. ( 24220442 )
2013
5
Pathology in practice. Nonepitheliotropic B-cell lymphoma of the nasal cavity with associated suppurative rhinitis and epidermal ulceration and lymphoma of the right kidney. ( 22380803 )
2012
6
[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. ( 17166382 )
2006
7
EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient. ( 16364984 )
2006
8
Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. ( 12576916 )
2003
9
Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. ( 11728681 )
2001
10
Primary non-Hodgkin's lymphoma of the nasal cavity. Clinical case report and discussion. ( 10958410 )
2000
11
Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. ( 9690537 )
1998
12
Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. ( 9240537 )
1997
13
Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. ( 9241082 )
1997
14
[Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases]. ( 1890745 )
1991
15
Primary lymphoma of the nasal cavity. A case report. ( 3616212 )
1987

Variations for Nasal Cavity Lymphoma

Expression for Nasal Cavity Lymphoma

Search GEO for disease gene expression data for Nasal Cavity Lymphoma.

Pathways for Nasal Cavity Lymphoma

GO Terms for Nasal Cavity Lymphoma

Sources for Nasal Cavity Lymphoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....